
NICE Ltd.
NICE.TANICE Ltd. (NICE.TA) FAQ
Answers to the most common investor questions about NICE Ltd. (NICE.TA): fair value, dividend, earnings dates, risk and fundamentals.
Frequently asked questions about NICE Ltd.
What is NICE Ltd. (NICE.TA) stock?
NICE Ltd. is the company identified by ticker NICE.TA on this research page. Use the overview to review the business, financial results, valuation and related news.
What does NICE Ltd. do?
NICE Ltd., an Israeli enterprise founded in 1986 and headquartered in Ra'anana, delivers cutting-edge, AI-powered cloud platforms for digital business solutions to clients worldwide. The company, which rebranded from NICE-Systems Ltd. in June 2016, offers a comprehensive suite of products primarily across two critical areas: customer experience (CX) and financial crime and compliance. For customer experience enhancement, NICE provides its flagship CXone platform, an adaptable cloud-native solution supporting contact centers of all scales, from small, single-site operations to extensive networks with remote agents. Its Enlighten AI engine actively identifies automation prospects for self-service functionalities, while digital entry point solutions enable organizations to better cater to consumer demands. Additionally, journey orchestration solutions intelligently direct and connect customers using real-time AI routing. The company also offers smart self-service options for building data-driven automated conversations, along with prepared agent solutions that equip contact center staff with real-time guidance for effective problem resolution. Complete performance solutions help record both structured and unstructured customer interactions and transaction data. Furthermore, NICE Evidencentral serves as a vital digital evidence management platform for public safety bodies, including emergency communications, law enforcement, and criminal justice agencies. In the realm of financial crime and compliance, NICE's offerings include X-Sight, a flexible, open AI-cloud platform. It also offers Xceed, a dedicated cloud platform for comprehensive anti-money laundering (AML) and fraud prevention, particularly tailored for small and mid-sized organizations. Their data intelligence tools convert raw data into actionable insights, aiding in the prevention and detection of financial crimes. Leveraging advanced AI and analytics, NICE facilitates real-time financial crime detection. The company also supplies money laundering and fraud prevention systems to ensure adherence to capital markets and AML compliance regulations, alongside intelligent investigation tools and self-service capabilities that allow for customization and self-development.
Where can I find the NICE.TA stock price?
Check the NICE.TA quote and chart on the overview and Chart tabs. Confirm the quote time, currency and trading session before comparing prices; a research update time is not a quote timestamp.
What is the NICE.TA stock forecast and price target?
The Forecast tab shows available analyst price targets for NICE.TA. Analyst targets are separate from BTI scores and valuation estimates. Missing targets are unavailable, and forecasts do not guarantee returns.
Does NICE.TA pay dividends?
Review NICE Ltd.'s investor-relations announcements for declared dividends, ex-dividend dates and payment dates. A missing or zero yield in a data feed alone does not establish the company's dividend policy.
When does NICE.TA report earnings?
Check the Earnings tab for available dates and reported results, then confirm the next announcement with NICE Ltd.'s investor-relations calendar. Estimated dates may change.
How can I evaluate whether NICE.TA is overvalued?
Compare NICE.TA's Valuation and Financials tabs, including cash flow, growth assumptions and valuation multiples. BTI estimates depend on their inputs and are different from analyst price targets.
What risks should I review before investing in NICE.TA?
Review NICE Ltd.'s latest company filings for business-specific risks, alongside debt, profitability, competition and valuation. A BTI score summarizes research and is not a personalized investment recommendation.


